Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation

Area of Science:

• Proteomics
• Biomarker Discovery
• Analytical Chemistry

Background:

• Capillary electrophoresis-mass spectrometry (CE-MS) is a key proteomic platform for identifying biomarkers in biological samples.
• Biomarker sequence identity is crucial for understanding disease mechanisms and developing targeted therapies.
• Existing methods require robust peptide sequencing to complement CE-MS data.

Purpose of the Study:

• To discuss various peptide sequencing platforms for analyzing biomarkers identified by CE-MS.
• To highlight the unique capabilities of CE-MS in facilitating platform-independent peptide sequencing.
• To establish a reliable basis for assigning peptide sequence data to CE-MS parameters.

Main Methods:

• Comparison of different peptide sequencing platforms coupled with mass spectrometry (MS/MS) devices.
• Evaluation of on-line and off-line coupling strategies for separation and sequencing.
• Utilizing instruments like MALDI-TOF-TOF, ESI-IT, ESI-QTOF, and Fourier transform ion cyclotron resonance.

Main Results:

• CE-MS provides a reliable foundation for assigning peptide sequence data to CE migration time and molecular weight.
• Biomarker discovery using CE-MS allows for subsequent MS/MS sequence analysis independent of the separation method.
• A distinct correlation exists between amino acid composition and CE-MS migration time/molecular weight coordinates.

Conclusions:

• CE-MS is a powerful tool for biomarker discovery, enabling robust peptide sequencing.
• The platform-independent nature of CE-MS data facilitates diverse sequencing approaches.
• This facilitates the analysis of CE-MS-defined biomarkers from complex biological mixtures.